Publication | Closed Access

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

Phase Ii TrialMedicinePharmacologyBronchial Neoplasm2-H InfusionAnti-cancer AgentCancer TreatmentFirst-line ChemotherapyOncologyRadiation OncologyLung Cancer